Moleculin Biotech, Inc.
NASDAQ:MBRX
2.36 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.406 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.031 | 0.032 | 0.035 | 0.032 | 0.031 | 0.14 | 0.028 | 0.044 | 0.034 | 0.122 | 0.034 | 0.034 | 0.04 | 0.157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.031 | -0.032 | 0.371 | -0.032 | -0.031 | -0.14 | -0.028 | -0.044 | -0.034 | -0.122 | -0.034 | -0.034 | -0.04 | -0.157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.914 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 4.09 | 4.252 | 6.632 | 3.28 | 3.888 | 5.687 | 4.178 | 5.965 | 4.204 | 4.62 | 3.179 | 4.095 | 3.039 | 4.105 | 1.786 | 4.435 | 3.329 | 3.206 | 3.197 | 2.785 | 2.099 | 2.932 | 2.927 | 1.332 | 4.231 | 1.237 | 2.285 | 1.061 | 0.515 | 0.683 | 0.879 | 0.497 | 0.362 | 0.015 | 0.038 |
| General & Administrative Expenses
| 2.064 | 2.393 | 2.252 | 2.635 | 2.523 | 2.667 | 2.838 | 3.087 | 3.196 | 2.422 | 1.992 | 2.021 | 2.434 | 1.939 | 1.663 | 1.659 | 1.653 | 1.81 | 1.564 | 1.672 | 1.533 | 1.591 | 1.37 | 1.248 | 1.22 | 1.392 | 2.752 | 1.338 | 0.8 | 0.848 | 2,381.424 | 0.924 | 0.618 | 0.306 | 0.184 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.649 | 0 | 0 | 0 | -2,380.89 | 0 | 0 | 0 | 0 |
| SG&A
| 2.064 | 2.393 | 2.252 | 2.635 | 2.523 | 2.667 | 2.838 | 3.087 | 3.196 | 2.422 | 1.992 | 2.021 | 2.434 | 1.939 | 1.663 | 1.659 | 1.653 | 1.81 | 1.564 | 1.672 | 1.533 | 1.591 | 1.37 | 1.248 | 1.22 | 1.392 | 1.103 | 1.338 | 0.8 | 0.848 | 0.534 | 0.924 | 0.618 | 0.306 | 0.184 |
| Other Expenses
| 0.011 | 0.011 | -0.492 | 0.032 | 0.009 | 0.008 | 0.032 | 0.032 | 0.015 | 0.032 | 0.01 | 0.013 | 0.008 | 0.009 | -0.004 | 0.01 | 0.017 | 0.005 | 0.01 | 0.005 | 0.049 | 0.048 | -0.017 | -0.021 | -0.001 | 0.008 | 0.005 | 0.005 | 0.005 | 0.004 | 0.005 | 0.001 | 0.001 | 0 | 0 |
| Operating Expenses
| 6.154 | 6.645 | 8.884 | 5.947 | 6.411 | 8.354 | 7.048 | 9.084 | 7.434 | 7.074 | 5.205 | 6.157 | 5.517 | 6.088 | 3.495 | 6.151 | 5.034 | 5.062 | 4.813 | 4.508 | 3.632 | 4.571 | 4.338 | 2.591 | 5.458 | 2.637 | 3.393 | 2.404 | 1.32 | 1.535 | 1.417 | 1.422 | 0.98 | 0.321 | 0.223 |
| Operating Income
| -6.185 | -6.677 | -8.919 | -5.947 | -6.411 | -8.354 | -7.048 | -9.084 | -7.434 | -7.074 | -5.205 | -6.157 | -5.517 | -6.088 | -3.495 | -6.151 | -5.034 | -5.062 | -4.813 | -4.508 | -3.632 | -4.571 | -4.338 | -2.591 | -5.458 | -2.637 | -3.393 | -2.404 | -1.32 | -1.535 | -1.417 | -1.422 | -0.98 | -0.321 | -0.223 |
| Operating Income Ratio
| 0 | 0 | -21.968 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.866 | 1.707 | -1.35 | 0.338 | 0.045 | 0.439 | 0.278 | 0.473 | 0.618 | 0.207 | 2.31 | 1.691 | 1.181 | 1.586 | 0.853 | 2.753 | -5.082 | 3.85 | 1.013 | 0.129 | 2.407 | 0.529 | 1.554 | 0.552 | 0.33 | 0.709 | 0.206 | -0.461 | -2.104 | 1.207 | -0.006 | -0.01 | -0.015 | -0.012 | -0.002 |
| Income Before Tax
| -4.319 | -4.97 | -10.269 | -5.609 | -5.976 | -7.915 | -6.77 | -8.611 | -6.777 | -6.867 | -2.825 | -4.379 | -4.244 | -4.445 | -2.639 | -3.395 | -10.112 | -1.209 | -3.797 | -4.374 | -1.221 | -4.041 | -2.785 | -2.038 | -5.125 | -1.927 | -3.185 | -2.866 | -3.424 | -0.329 | -1.423 | -1.432 | -0.996 | -0.332 | -0.224 |
| Income Before Tax Ratio
| 0 | 0 | -25.293 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.011 | 0.965 | 0.072 | -0.457 | -0.508 | -1.142 | -0.033 | -0.642 | -0.207 | -2.37 | -1.765 | -1.265 | -1.634 | -0.86 | -2.745 | 5.095 | -3.848 | 0.229 | -0.229 | -2.46 | -0.53 | -1.57 | -0.574 | -0.334 | 0 | 1.15 | 0.001 | 0.001 | 0.001 | 0 | 0.257 | 0 | -0.321 | -0.002 |
| Net Income
| -4.319 | -4.97 | -10.269 | -5.609 | -5.976 | -7.407 | -5.628 | -8.578 | -6.777 | -6.66 | -2.825 | -4.379 | -4.244 | -4.445 | -2.639 | -3.395 | -10.112 | -1.209 | -3.797 | -4.145 | -1.221 | -4.041 | -2.785 | -2.038 | -5.125 | -1.927 | -3.185 | -2.866 | -3.424 | -0.329 | -1.423 | -1.432 | -0.996 | -0.332 | -0.224 |
| Net Income Ratio
| 0 | 0 | -25.293 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.7 | -2.02 | -5.13 | -2.82 | -3.02 | -3.86 | -2.95 | -0.3 | -0.24 | -0.23 | -0.11 | -0.15 | -0.15 | -0.2 | -0.27 | -0.33 | -1.02 | -0.15 | -0.56 | -0.55 | -0.17 | -0.83 | -0.65 | -0.46 | -1.19 | -0.5 | -1.03 | -0.84 | -1.15 | -0.14 | -0.87 | -0.74 | -0.67 | -0.14 | -4.67 |
| EPS Diluted
| -1.7 | -2.02 | -5.13 | -2.82 | -3.02 | -3.86 | -2.95 | -0.3 | -0.24 | -0.23 | -0.11 | -0.15 | -0.15 | -0.2 | -0.27 | -0.33 | -1.02 | -0.15 | -0.56 | -0.55 | -0.17 | -0.83 | -0.65 | -0.46 | -1.19 | -0.5 | -1.03 | -0.84 | -1.15 | -0.14 | -0.87 | -0.74 | -0.67 | -0.14 | -4.67 |
| EBITDA
| -6.154 | -6.645 | -8.884 | -5.915 | -6.447 | -8.393 | -7.167 | -9.473 | -8.003 | -7.202 | -7.471 | -7.793 | -6.646 | -7.621 | -4.306 | -8.837 | 0.117 | -8.861 | -5.764 | -4.581 | -6.039 | -5.052 | -5.868 | -3.152 | -5.782 | -2.628 | -2.236 | -2.399 | -1.315 | -1.531 | -1.413 | -1.421 | -0.98 | -0.321 | -0.002 |
| EBITDA Ratio
| 0 | 0 | -21.882 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |